SCHEMBL21975249

SCHEMBL21975249

c1ccc(-c2nc3ccccc3nc2-c2ccc(C3(c4ccc5c(c4)sc4ccccc45)c4ccccc4-c4ccccc43)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 6/20 0.37
KDM4E B2RXH2 9/20 0.37
LMNA P02545 6/20 0.37
KMT2A Q03164 3/20 0.37
GAA P10253 3/20 0.37
MEN1 O00255 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
AKT1 P31749 2/20 0.36
AKT2 P31751 1/20 0.36
ALDH1A1 P00352 7/20 0.35
ATM Q13315 1/20 0.35
TLR9 Q9NR96 1/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
MAPT P10636 2/20 0.35
OPRK1 P41145 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
THRB P10828 1/20 0.34
HPGD P15428 2/20 0.34
RAB9A P51151 2/20 0.34
NPC1 O15118 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21975465 0.93 L3MBTL1 (0.37) L3MBTL1KDM4ELMNAKMT2AGAA
SCHEMBL21975544 0.89 MEN1 (0.45) KDM4ELMNAKMT2AGAAMEN1
SCHEMBL21975250 0.89 KDM4E (0.32) L3MBTL1KDM4ELMNAKMT2AMEN1
SCHEMBL21975543 0.88 MEN1 (0.44) KDM4ELMNAKMT2AGAAMEN1
SCHEMBL21976044 0.87 MEN1 (0.40) L3MBTL1KDM4ELMNAKMT2AMEN1
SCHEMBL21975463 0.86 MAPT (0.39) L3MBTL1KDM4ELMNAKMT2AMEN1
SCHEMBL21976046 0.86 MAPT (0.39) L3MBTL1KDM4ELMNAKMT2AMEN1
SCHEMBL21975180 0.86 MAPT (0.39) L3MBTL1KDM4ELMNAKMT2AMEN1
SCHEMBL21975661 0.86 MAPT (0.39) L3MBTL1KDM4ELMNAKMT2AMEN1
SCHEMBL21975172 0.84 MAPT (0.45) L3MBTL1KDM4ELMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200144511-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DOOSAN CORPORATION (KR) 2020-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200144511-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OR10J3, ORAI2, ORC3 L3MBTL1 794/4885KDM4E 933/4885LMNA 2199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.